Anupam Rasayan Q1 Results: Profit Rises 24.6%, Beats Estimates
Anupam Rasayan India Ltd.'s first-quarter profit rose, beating analysts' estimates.
The company's net profit rose 24.6% year-on-year to Rs 52.2 crore in the quarter ended June, according to an exchange filing on Tuesday. This compares with a Bloomberg estimate of Rs 48.05 crore.
Anupam Rasayan India Q1 FY24 Highlights (Consolidated, YoY)
Revenues up 12.4% at Rs 386.3 crore. (Bloomberg estimate: Rs 408.08 crore)
Ebitda up 2.8% at Rs 101.3 crore. (Bloomberg estimate: Rs 102.92 crore)
Margins at 26.2% vs 28.7% (Bloomberg estimate: 25.22%).
Net profit up 24.6% at Rs 52.2 crore. (Bloomberg estimate: Rs 48.05 crore).
"I am delighted at the consistent growth momentum of the company against a challenging industry backdrop. Our consolidated revenue witnessed robust 19% year-on-year growth at Rs 398.8 crore. While the falling prices of commodity agrochemicals are putting pressure on margins for the industry, our customised products and robust business model helped us deliver strong Ebitda margins in Q1 FY24," said Managing Director Anand Desai.
During the quarter, Anupam Rasayan signed an MoU with 3xper Innoventure Ltd. for the supply of targeted and identified new-age pharma molecules using a continuous process. The company has also signed letters of intent worth Rs 4,066 crore with Japanese and American MNCs for niche life sciences and specialty chemical molecules. These LOIs reinforce the growing confidence of global MNCs in our technical capabilities and think of us as the trusted partner of choice for high-end customised molecules. These LOIs improves our revenue visibility in the coming years, he said
The company incurred capex of Rs 124 crore till Q1 FY24 out of the Rs 670 crore announced, with the majority of the capex to be incurred as per plan in FY24.
The company has signed letters Of intent and contracts worth Rs 7,669 crore in the last two years, providing strong visibility of revenue for the coming years.
Anupam is expanding into fluorination chemistry, wherein the company will source fluorinating agents potassium fluoride and Hydrogen fluoride from Tanfac (which it acquired in March with a 25.80% stake) and manufacture value-added products at Anupam.
For most of this products, Anupam will be single supplier out of Asia on exclusive basis to originators
Shares of Anupam Rasayan rose 0.01% to Rs 975 apiece as of 9:46 a.m., compared with a rise of 0.12% in the benchmark NSE Nifty 50.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
